90
Participants
Start Date
March 29, 2018
Primary Completion Date
March 1, 2021
Study Completion Date
March 1, 2021
AMX0035
Combination therapy of PB and TURSO
The Penn Comprehensive Neuroscience Center, Philadelphia
Temple University Hospital, Philadelphia
Johns Hopkins Hospital, Baltimore
Wake Forest School of Medicine, Winston-Salem
Emory University Hospital, Atlanta
University of Florida College of Medicine, Gainesville
University of South Florida College of Medicine, Tampa
University of Kentucky Medical Center, Lexington
The Ohio State University, Wexner Medical Center, Columbus
University of Michigan, Michigan Medicine, Ann Arbor
University of Iowa, Carver College of Medicine, Iowa City
Hennepin County Medical Center, Minneapolis
Washington University Medical Center, St Louis
Neurology Associates, PC, Lincoln
Ochsner Neuroscience Institute, New Orleans
Texas Neurology, PA, Dallas
University of Texas Health Science Center, San Antonio, San Antonio
Barrow Neurological Institute-Dignity Health, St Joseph's Hospital and Medical Center, Phoenix
University of California, Irvine, Orange
California Pacific Medical Center, San Francisco
Oregon Health & Science University, Portland
Swedish Neuroscience Center, Seattle
Massachusetts General Hospital, Boston
University of Massachusetts Memorial Medical Center, Worcester
Lead Sponsor
Massachusetts General Hospital
OTHER
Amylyx Pharmaceuticals Inc.
INDUSTRY